| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 药品生产与销售(元) | 1,494,503,289.06 | 776,500,856.38 | 1,493,178,383.13 | 735,606,199.46 |
| 医疗服务(元) | 1,649,172,193.54 | 807,599,029.60 | 1,740,050,342.05 | 754,810,951.99 |
| 其他(元) | 53,648,805.42 | 16,971,122.23 | 48,221,829.55 | 20,557,016.18 |
| 营业成本(元) | ||||
| 药品生产与销售(元) | 956,989,635.10 | 526,391,343.51 | 1,028,342,912.79 | 479,936,149.19 |
| 医疗服务(元) | 1,554,644,544.31 | 737,267,148.51 | 1,602,682,223.32 | 696,227,926.79 |
| 其他(元) | 57,867,500.23 | 16,824,110.04 | 44,749,891.79 | 17,955,504.38 |
| 毛利(元) | ||||
| 药品生产与销售(元) | 537,513,653.96 | 250,109,512.87 | 464,835,470.34 | 255,670,050.27 |
| 医疗服务(元) | 94,527,649.23 | 70,331,881.09 | 137,368,118.73 | 58,583,025.20 |
| 其他(元) | -4,218,694.81 | 147,012.19 | 3,471,937.76 | 2,601,511.80 |
| 毛利率(%) | ||||
| 药品生产与销售(%) | 35.97 | 32.21 | 31.13 | 34.76 |
| 医疗服务(%) | 5.73 | 8.71 | 7.89 | 7.76 |
| 其他(%) | -7.86 | 0.87 | 7.20 | 12.66 |
| 收入构成(%) | ||||
| 药品生产与销售(%) | 46.74 | 48.50 | 45.50 | 48.68 |
| 医疗服务(%) | 51.58 | 50.44 | 53.03 | 49.96 |
| 其他(%) | 1.68 | 1.06 | 1.47 | 1.36 |
| 毛利构成(%) | ||||
| 药品生产与销售(%) | 85.62 | 78.02 | 76.75 | 80.69 |
| 医疗服务(%) | 15.06 | 21.94 | 22.68 | 18.49 |
| 其他(%) | -0.67 | 0.05 | 0.57 | 0.82 |